In a significant breakthrough in the fight against Alzheimer’s and age-related cognitive decline, a new study has revealed ...

Unlike expensive positron emission tomography (PET) scans or invasive lumbar punctures, the new blood test measures the ratio of two proteins, pTau217 and ß-Amyloid 1-42, which are implicated in ...

"The scale at which we analyzed the amyloid peptides was unprecedented," said Ben Lehner of the Wellcome Sanger Institute.

A surprising new study has uncovered over 200 misfolded proteins in the brains of aging rats with cognitive decline, beyond ...

Neuroscientists have taken a major step toward detecting Alzheimer’s disease in its earliest stages—long before memory loss ...

Understand the 6 stages of Alzheimer’s disease, from early signs to final care, and how families can support loved ones ...

For decades, Alzheimer’s disease has resisted nearly every significant pharmaceutical intervention. Despite billions invested ...

Alzheimer’s may be driven by more than just plaques—scientists have discovered 200+ hidden proteins that could be quietly ...

Leqembi and Kisunla don’t just reduce amyloid plaques that are implicated in Alzheimer’s disease. According to new research, the drugs boost levels of a healthy form of amyloid beta (Aβ42 ...

Altering cellular interactions around amyloid plaques may offer novel Alzheimer's treatment strategies. ScienceDaily . Retrieved June 2, 2025 from www.sciencedaily.com / releases / 2024 / 05 ...

Once again looking at how suppressing PDE4B might affect the brain, the UK team genetically modified mice with Alzheimer's and amyloid plaques in the brain to have reduced PDE4B activity.

New research suggests that the lessening of amyloid-beta in the brain is behind cognitive decline in Alzheimer's and boosting brain protein amounts may offer cognitive benefits.